HEADER TRANSFERASE 18-APR-07 2PL0 TITLE LCK BOUND TO IMATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE; COMPND 5 SYNONYM: P56-LCK, LYMPHOCYTE CELL-SPECIFIC PROTEIN-TYROSINE KINASE, COMPND 6 LSK, T CELL- SPECIFIC PROTEIN-TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LCK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBEV1 KEYWDS KINASE PHOSPHORYLATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.D.JACOBS REVDAT 5 21-FEB-24 2PL0 1 REMARK SEQADV HETSYN REVDAT 4 24-FEB-09 2PL0 1 VERSN REVDAT 3 26-FEB-08 2PL0 1 JRNL REVDAT 2 20-NOV-07 2PL0 1 JRNL REVDAT 1 09-OCT-07 2PL0 0 JRNL AUTH M.D.JACOBS,P.R.CARON,B.J.HARE JRNL TITL CLASSIFYING PROTEIN KINASE STRUCTURES GUIDES USE OF JRNL TITL 2 LIGAND-SELECTIVITY PROFILES TO PREDICT INACTIVE JRNL TITL 3 CONFORMATIONS: STRUCTURE OF LCK/IMATINIB COMPLEX. JRNL REF PROTEINS V. 70 1451 2007 JRNL REFN ISSN 0887-3585 JRNL PMID 17910071 JRNL DOI 10.1002/PROT.21633 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1044136.688 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 10474 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 534 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2520 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2500 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 534 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 10474 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1624 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 68 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.040 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2182 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -18.32000 REMARK 3 B22 (A**2) : 17.39000 REMARK 3 B33 (A**2) : 0.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.60 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.550 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.410 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.520 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.920 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.120 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 47.07 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : INHIB.PAR REMARK 3 PARAMETER FILE 4 : PARMXRAY.XPL REMARK 3 PARAMETER FILE 5 : &_1_PARAMETER_INFILE_5 REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : INHIB.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PL0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042493. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10512 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 29.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.870 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.99 REMARK 200 R MERGE FOR SHELL (I) : 0.40900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M AMMONIUM SULFATE, 100 MM HEPES REMARK 280 PH 7.5, 1% PEG-3350, 10 MM DTT, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 37.60500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.58500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.60500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.58500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 221 REMARK 465 SER A 222 REMARK 465 HIS A 223 REMARK 465 MET A 224 REMARK 465 GLN A 225 REMARK 465 THR A 226 REMARK 465 GLN A 227 REMARK 465 LYS A 228 REMARK 465 PRO A 229 REMARK 465 GLN A 230 REMARK 465 THR A 499 REMARK 465 ALA A 500 REMARK 465 THR A 501 REMARK 465 GLU A 502 REMARK 465 GLY A 503 REMARK 465 GLN A 504 REMARK 465 TYR A 505 REMARK 465 GLN A 506 REMARK 465 PRO A 507 REMARK 465 GLN A 508 REMARK 465 PRO A 509 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 231 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 256 12.07 -149.48 REMARK 500 HIS A 297 145.50 -179.84 REMARK 500 ASN A 359 43.12 70.88 REMARK 500 ARG A 363 -24.94 88.99 REMARK 500 ALA A 396 31.32 -145.94 REMARK 500 ASN A 464 -23.22 72.25 REMARK 500 PRO A 485 176.84 -58.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STI A 200 DBREF 2PL0 A 225 509 UNP P06239 LCK_HUMAN 225 509 SEQADV 2PL0 GLY A 221 UNP P06239 EXPRESSION TAG SEQADV 2PL0 SER A 222 UNP P06239 EXPRESSION TAG SEQADV 2PL0 HIS A 223 UNP P06239 EXPRESSION TAG SEQADV 2PL0 MET A 224 UNP P06239 EXPRESSION TAG SEQRES 1 A 289 GLY SER HIS MET GLN THR GLN LYS PRO GLN LYS PRO TRP SEQRES 2 A 289 TRP GLU ASP GLU TRP GLU VAL PRO ARG GLU THR LEU LYS SEQRES 3 A 289 LEU VAL GLU ARG LEU GLY ALA GLY GLN PHE GLY GLU VAL SEQRES 4 A 289 TRP MET GLY TYR TYR ASN GLY HIS THR LYS VAL ALA VAL SEQRES 5 A 289 LYS SER LEU LYS GLN GLY SER MET SER PRO ASP ALA PHE SEQRES 6 A 289 LEU ALA GLU ALA ASN LEU MET LYS GLN LEU GLN HIS GLN SEQRES 7 A 289 ARG LEU VAL ARG LEU TYR ALA VAL VAL THR GLN GLU PRO SEQRES 8 A 289 ILE TYR ILE ILE THR GLU TYR MET GLU ASN GLY SER LEU SEQRES 9 A 289 VAL ASP PHE LEU LYS THR PRO SER GLY ILE LYS LEU THR SEQRES 10 A 289 ILE ASN LYS LEU LEU ASP MET ALA ALA GLN ILE ALA GLU SEQRES 11 A 289 GLY MET ALA PHE ILE GLU GLU ARG ASN TYR ILE HIS ARG SEQRES 12 A 289 ASP LEU ARG ALA ALA ASN ILE LEU VAL SER ASP THR LEU SEQRES 13 A 289 SER CYS LYS ILE ALA ASP PHE GLY LEU ALA ARG LEU ILE SEQRES 14 A 289 GLU ASP ASN GLU TYR THR ALA ARG GLU GLY ALA LYS PHE SEQRES 15 A 289 PRO ILE LYS TRP THR ALA PRO GLU ALA ILE ASN TYR GLY SEQRES 16 A 289 THR PHE THR ILE LYS SER ASP VAL TRP SER PHE GLY ILE SEQRES 17 A 289 LEU LEU THR GLU ILE VAL THR HIS GLY ARG ILE PRO TYR SEQRES 18 A 289 PRO GLY MET THR ASN PRO GLU VAL ILE GLN ASN LEU GLU SEQRES 19 A 289 ARG GLY TYR ARG MET VAL ARG PRO ASP ASN CYS PRO GLU SEQRES 20 A 289 GLU LEU TYR GLN LEU MET ARG LEU CYS TRP LYS GLU ARG SEQRES 21 A 289 PRO GLU ASP ARG PRO THR PHE ASP TYR LEU ARG SER VAL SEQRES 22 A 289 LEU GLU ASP PHE PHE THR ALA THR GLU GLY GLN TYR GLN SEQRES 23 A 289 PRO GLN PRO HET STI A 200 37 HETNAM STI 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4- HETNAM 2 STI PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE HETSYN STI STI-571; IMATINIB FORMUL 2 STI C29 H31 N7 O FORMUL 3 HOH *93(H2 O) HELIX 1 1 PRO A 232 ASP A 236 5 5 HELIX 2 2 PRO A 241 GLU A 243 5 3 HELIX 3 3 SER A 281 LEU A 295 1 15 HELIX 4 4 SER A 323 THR A 330 1 8 HELIX 5 5 THR A 330 LYS A 335 1 6 HELIX 6 6 THR A 337 ARG A 358 1 22 HELIX 7 7 ARG A 366 ALA A 368 5 3 HELIX 8 8 LEU A 385 ILE A 389 5 5 HELIX 9 9 PRO A 403 THR A 407 5 5 HELIX 10 10 ALA A 408 GLY A 415 1 8 HELIX 11 11 THR A 418 VAL A 434 1 17 HELIX 12 12 THR A 445 ARG A 455 1 11 HELIX 13 13 PRO A 466 TRP A 477 1 12 HELIX 14 14 ARG A 480 ARG A 484 5 5 HELIX 15 15 THR A 486 ASP A 496 1 11 SHEET 1 A 5 LEU A 245 ARG A 250 0 SHEET 2 A 5 VAL A 259 TYR A 264 -1 O MET A 261 N VAL A 248 SHEET 3 A 5 THR A 268 SER A 274 -1 O VAL A 272 N TRP A 260 SHEET 4 A 5 TYR A 313 GLU A 317 -1 O ILE A 314 N LYS A 273 SHEET 5 A 5 LEU A 303 VAL A 307 -1 N ALA A 305 O ILE A 315 SHEET 1 B 2 ILE A 370 VAL A 372 0 SHEET 2 B 2 CYS A 378 ILE A 380 -1 O LYS A 379 N LEU A 371 CISPEP 1 GLU A 310 PRO A 311 0 -9.40 SITE 1 AC1 16 HOH A 86 ALA A 271 LYS A 273 GLU A 288 SITE 2 AC1 16 LEU A 291 MET A 292 VAL A 301 ILE A 314 SITE 3 AC1 16 THR A 316 TYR A 318 MET A 319 ILE A 361 SITE 4 AC1 16 HIS A 362 ALA A 381 ASP A 382 PHE A 383 CRYST1 75.210 103.170 52.330 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013296 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009693 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019109 0.00000